BRPI0817234A2 - Análogos de azacitidina e seus usos - Google Patents
Análogos de azacitidina e seus usosInfo
- Publication number
- BRPI0817234A2 BRPI0817234A2 BRPI0817234-0A2A BRPI0817234A BRPI0817234A2 BR PI0817234 A2 BRPI0817234 A2 BR PI0817234A2 BR PI0817234 A BRPI0817234 A BR PI0817234A BR PI0817234 A2 BRPI0817234 A2 BR PI0817234A2
- Authority
- BR
- Brazil
- Prior art keywords
- azacitidine
- analogs
- azacitidine analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/12—Triazine radicals
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97543707P | 2007-09-26 | 2007-09-26 | |
PCT/US2008/077673 WO2009042767A1 (en) | 2007-09-26 | 2008-09-25 | Azacytidine analogues and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0817234A2 true BRPI0817234A2 (pt) | 2014-09-30 |
Family
ID=40511851
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0817234-0A2A BRPI0817234A2 (pt) | 2007-09-26 | 2008-09-25 | Análogos de azacitidina e seus usos |
BRPI0817269-2A2A BRPI0817269A2 (pt) | 2007-09-26 | 2008-09-25 | Análogos de azacitidina e usos dos mesmos |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0817269-2A2A BRPI0817269A2 (pt) | 2007-09-26 | 2008-09-25 | Análogos de azacitidina e usos dos mesmos |
Country Status (15)
Country | Link |
---|---|
US (2) | US8399420B2 (pt) |
EP (2) | EP2197274A4 (pt) |
JP (2) | JP2010540556A (pt) |
KR (2) | KR20100072230A (pt) |
CN (2) | CN101877964A (pt) |
AU (2) | AU2008304381A1 (pt) |
BR (2) | BRPI0817234A2 (pt) |
CA (2) | CA2700207A1 (pt) |
IL (1) | IL204690A0 (pt) |
MX (2) | MX2010003002A (pt) |
NZ (2) | NZ583824A (pt) |
RU (1) | RU2488591C2 (pt) |
UA (2) | UA99308C2 (pt) |
WO (2) | WO2009042766A1 (pt) |
ZA (1) | ZA201001660B (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8497292B2 (en) * | 2005-12-28 | 2013-07-30 | Translational Therapeutics, Inc. | Translational dysfunction based therapeutics |
NZ583824A (en) | 2007-09-26 | 2012-06-29 | Sinai School Medicine | Azacytidine analogues and uses thereof |
SI2299984T1 (sl) | 2008-05-15 | 2019-04-30 | Celgene Corporation | Oralne formulacije analogov citidina in postopki njihove uporabe |
EP2321302B1 (en) * | 2008-08-01 | 2014-10-29 | Dr. Reddy's Laboratories Ltd. | Azacitidine process and polymorphs |
AR076418A1 (es) * | 2009-04-27 | 2011-06-08 | Reddys Lab Inc Dr | Preparacion de decitabina |
CN103338753A (zh) | 2011-01-31 | 2013-10-02 | 细胞基因公司 | 胞苷类似物的药物组合物及其使用方法 |
TW201303295A (zh) * | 2011-04-15 | 2013-01-16 | Clavis Pharma Asa | 偵測血液失調中之人平衡型核苷轉運蛋白1(hENT1)表現用之系統和方法 |
CA2853949A1 (en) | 2011-11-01 | 2013-05-10 | Celgene Corporation | Methods for treating cancers using oral formulations of cytidine analogs |
EA028462B1 (ru) | 2012-02-24 | 2017-11-30 | СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Способы лечения немелкоклеточного рака легких на поздних стадиях c применением комбинированного лечения с ингибитором киназы tor |
US9493500B2 (en) | 2012-07-19 | 2016-11-15 | Richard Daifuku | Fluorinated pyrimidine analogs and methods of use thereof |
NZ631082A (en) * | 2013-04-17 | 2017-06-30 | Signal Pharm Llc | Methods for treating cancer using tor kinase inhibitor combination therapy |
WO2015195786A2 (en) | 2014-06-17 | 2015-12-23 | Celgene Corporation | Methods for treating cancers using oral formulations of cytidine analogs |
WO2017090264A1 (ja) | 2015-11-27 | 2017-06-01 | 大原薬品工業株式会社 | 5-アザシチジン又は其の2'-デオキシ体の5'位ジベンジル燐酸エステル |
EP3383406B1 (en) | 2015-12-03 | 2021-10-20 | Epidestiny, Inc. | Compositions containing decitabine, 5-azacytidine and tetrahydrouridine and uses thereof |
MX2019011130A (es) | 2017-03-20 | 2019-11-05 | Vaccinex Inc | Tratamiento del cancer con un anticuerpo semaforina-4d en combinacion con un agente de modulacion epigenetica. |
BR112019027402A2 (pt) | 2017-06-22 | 2020-07-07 | Celgene Corporation | tratamento de carcinoma hepatocelular caracterizado por infecção pelo vírus da hepatite b |
AU2019256465A1 (en) * | 2018-04-19 | 2020-11-26 | Southern Research Institute | 4'-thio-nucleotide and -nucleoside prodrugs for the treatment of cancer |
US20230416294A1 (en) * | 2020-08-10 | 2023-12-28 | The Johns Hopkins University | Decitabine analogs for immunological and oncological therapy |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE612384A (fr) * | 1961-01-10 | 1962-05-02 | Spofa Vereinigte Pharma Werke | Procédé de préparation des 1-glycosyle-6-aza-uraciles |
GB1050899A (pt) * | 1963-12-22 | |||
DE2012888C3 (de) | 1970-03-14 | 1981-04-02 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden |
DE2122991C2 (de) * | 1971-05-04 | 1982-06-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von Cytosin- und 6-Azacytosinnucleosiden |
US3984396A (en) * | 1971-06-01 | 1976-10-05 | Icn Pharmaceuticals, Inc. | 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters |
US3998807A (en) * | 1972-03-03 | 1976-12-21 | Syntex (U.S.A.) Inc. | Arabinofuranosyl cytosines and methods of making |
US4172889A (en) | 1976-03-29 | 1979-10-30 | The Upjohn Company | Method of treating rheumatoid arthritis |
US4405611A (en) | 1980-06-27 | 1983-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | Bisulfite stabilization of 5-azacytidine |
DE3100478A1 (de) | 1981-01-09 | 1982-08-12 | Dr. Thilo & Co GmbH, 8021 Sauerlach | 5'ester von pyrimidinnucleosiden mit antiviraler wirksamkeit, verfahren zur herstellung und daraus hergestellte arzneimittel |
SU961354A1 (ru) * | 1981-02-18 | 1985-08-07 | Институт биоорганической химии АН БССР | 3-Фтор-2,3-дидезоксиаденозин,про вл ющий цитостатическую активность |
US5223263A (en) | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
DE3737456A1 (de) | 1986-11-04 | 1988-05-19 | Fuji Photo Film Co Ltd | Laserlichtquelle |
CS264456B1 (cs) | 1987-08-28 | 1989-08-14 | Piskala Alois | Způsob výroby 5,6-dihydro-S-azacytidinu |
CS264454B1 (cs) | 1987-08-28 | 1989-08-14 | Piskala Alois | 2'-Deoxy-5,6-dihydro-5-azacytidin a způsob jeho výroby |
US5994392A (en) | 1988-02-26 | 1999-11-30 | Neuromedica, Inc. | Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid |
US4984396A (en) * | 1988-08-29 | 1991-01-15 | Uragami Fukashi | Cleaning device |
DE3834435A1 (de) * | 1988-10-10 | 1990-06-13 | Basf Ag | Verbrueckte, wasserloesliche copolymerisate, verfahren zu ihrer herstellung und ihre verwendung |
US5216142A (en) | 1989-04-17 | 1993-06-01 | Efamol Holdings Plc | Anti-virals |
JP2559917B2 (ja) * | 1990-06-15 | 1996-12-04 | 三共株式会社 | ピリミジンヌクレオシド誘導体 |
DE4026265A1 (de) | 1990-08-20 | 1992-02-27 | Boehringer Mannheim Gmbh | Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel |
WO1992015113A1 (en) * | 1991-02-19 | 1992-09-03 | Fujitsu Limited | Semiconductor device having an isolation region enriched in oxygen and a fabrication process thereof |
US5385912A (en) * | 1991-03-08 | 1995-01-31 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Multicyclic tertiary amine polyaromatic squalene synthase inhibitors |
US5480883A (en) | 1991-05-10 | 1996-01-02 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
ZA923641B (en) | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
HUT70144A (en) | 1991-08-14 | 1995-09-28 | Procter & Gamble Pharma | Cyclic urethaanes useful as antiarrhythmic and antifibrillatory agents, pharmaceutical compositions containing them, and process for their preparation |
GB2260319B (en) | 1991-10-07 | 1995-12-06 | Norsk Hydro As | Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity |
GB9307043D0 (en) * | 1993-04-05 | 1993-05-26 | Norsk Hydro As | Chemical compounds |
GB9515279D0 (en) | 1995-07-25 | 1995-09-20 | Norsk Hydro As | Improved therapeutic agents |
DE19505168A1 (de) | 1995-02-16 | 1996-08-22 | Boehringer Mannheim Gmbh | Spezifische Lipidkonjugate von Nucleosid-Diphosphonaten und deren Verwendung als Arzneimittel |
WO1997005143A1 (fr) | 1995-07-25 | 1997-02-13 | Asahi Kasei Kogyo Kabushiki Kaisha | Nouveaux composes a base de metaux de transition du groupe 4 |
WO1997006242A1 (en) | 1995-08-08 | 1997-02-20 | Thomas Jefferson University | Recombinant c-proteinase and processes, methods and uses thereof |
CA2229414A1 (en) | 1995-09-15 | 1997-03-20 | Anadys Pharmaceuticals, Inc. | Arylhydrazone derivatives useful as antibacterial agents |
US5919815A (en) * | 1996-05-22 | 1999-07-06 | Neuromedica, Inc. | Taxane compounds and compositions |
US6576636B2 (en) * | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
JP4172726B2 (ja) * | 1996-05-22 | 2008-10-29 | ルイトポルド・ファーマシューティカルズ・インコーポレーテッド | シス―ドコサヘキサエン酸とドセタキセルとの共有複合体を含有する製剤 |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
JPH10158192A (ja) | 1996-10-03 | 1998-06-16 | Eisai Co Ltd | 移植片対宿主疾患(gvhd)の治療および臓器移植時の移植片拒絶反応抑制のための医薬組成物 |
DE69812934T2 (de) * | 1997-01-24 | 2004-01-29 | Conpharma As Oslo | Gemcitabin-derivate |
GB2321455A (en) | 1997-01-24 | 1998-07-29 | Norsk Hydro As | Lipophilic derivatives of biologically active compounds |
EP0997473B1 (en) * | 1997-06-03 | 2003-04-09 | ITOCHU Techno-Chemical Inc. | Natural antitumor or antiviral substances and use of the same |
AU1412299A (en) | 1997-11-25 | 1999-06-15 | Protarga, Inc. | Nucleoside analog compositions and uses thereof |
EP1078917A4 (en) | 1998-02-17 | 2002-11-06 | Ono Pharmaceutical Co | AMIDINO DERIVATIVES FOR USE AS ACTIVE INGREDIENTS AND MEDICINES CONTAINING THEM |
AU5073100A (en) | 1999-06-09 | 2001-01-02 | Bayer Aktiengesellschaft | Pyridine carboxamides and their use as plant protection agents |
US6752981B1 (en) | 1999-09-08 | 2004-06-22 | Metabasis Therapeutics, Inc. | Prodrugs for liver specific drug delivery |
CZ20021653A3 (cs) | 1999-10-15 | 2002-08-14 | F. Hoffmann-La Roche Ag | Nové deriváty benzodiazepinu |
US6670341B1 (en) * | 1999-10-28 | 2003-12-30 | Wake Forest University Health Sciences | Compositions and methods for double-targeting virus infections and targeting cancer cells |
AU2002356672A1 (en) | 2001-11-21 | 2003-06-10 | Ganymed 256 Vermogensverwaltungs Gmbh | Phospholipid derivitives of nucleosides as antitumoral medicaments |
US6998391B2 (en) | 2002-02-07 | 2006-02-14 | Supergen.Inc. | Method for treating diseases associated with abnormal kinase activity |
EP1545558A4 (en) | 2002-09-24 | 2010-02-17 | Koronis Pharmaceuticals Inc | 1, 3, 5-TRIAZINES FOR THE TREATMENT OF VIRAL DISEASES |
US6887855B2 (en) | 2003-03-17 | 2005-05-03 | Pharmion Corporation | Forms of 5-azacytidine |
US7038038B2 (en) | 2003-03-17 | 2006-05-02 | Pharmion Corporation | Synthesis of 5-azacytidine |
US6943249B2 (en) | 2003-03-17 | 2005-09-13 | Ash Stevens, Inc. | Methods for isolating crystalline Form I of 5-azacytidine |
JPWO2004101593A1 (ja) | 2003-05-16 | 2006-07-13 | キッセイ薬品工業株式会社 | 5’−修飾ヌクレオシド誘導体及びその医薬用途 |
US7244732B2 (en) | 2003-06-20 | 2007-07-17 | Koronis Pharmaceuticals, Incorporated | Prodrugs of heteroaryl compounds |
GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
CA2548283A1 (en) | 2003-12-19 | 2005-07-21 | Koronis Pharmaceuticals, Inc. | Mutagenic heterocycles |
US20080188527A1 (en) | 2003-12-23 | 2008-08-07 | Cashman John R | Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer |
US20080227772A1 (en) | 2004-02-04 | 2008-09-18 | Neurosearch A/S | Diazabicyclic Aryl Derivatives as Nicotinic Acetylcholine Receptor Ligands |
US7192781B2 (en) | 2004-04-13 | 2007-03-20 | Pharmion Corporation | Methods for stabilizing 5-azacytidine in plasma |
US8158770B2 (en) | 2004-05-06 | 2012-04-17 | University Of Rochester | Content dependent inhibitors of cytidine deaminases and uses thereof |
GB0419416D0 (en) | 2004-09-01 | 2004-10-06 | Inst Of Ex Botany Ascr | 4-Arylazo-3,5-Diamino-Pyrazole compounds and use thereof |
US20060063735A1 (en) * | 2004-09-17 | 2006-03-23 | Supergen, Inc. | Salts of 5-azacytidine |
EP1809620B1 (en) | 2004-11-04 | 2010-12-29 | Addex Pharma SA | Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
US20060128654A1 (en) | 2004-12-10 | 2006-06-15 | Chunlin Tang | Pharmaceutical formulation of cytidine analogs and derivatives |
US7250416B2 (en) | 2005-03-11 | 2007-07-31 | Supergen, Inc. | Azacytosine analogs and derivatives |
US20090074848A1 (en) * | 2005-09-19 | 2009-03-19 | Sharon Johnstone | Combination formulations of cytidine analogs and platinum agents |
JP5114202B2 (ja) | 2005-09-27 | 2013-01-09 | 塩野義製薬株式会社 | Pgd2受容体アンタゴニスト活性を有するスルホンアミド誘導体 |
NO324263B1 (no) | 2005-12-08 | 2007-09-17 | Clavis Pharma Asa | Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser |
US20070225248A1 (en) | 2006-03-21 | 2007-09-27 | Clavis Pharma As | Oral dosage forms of gemcitabine derivatives |
NZ583824A (en) | 2007-09-26 | 2012-06-29 | Sinai School Medicine | Azacytidine analogues and uses thereof |
-
2008
- 2008-09-25 NZ NZ583824A patent/NZ583824A/en not_active IP Right Cessation
- 2008-09-25 UA UAA201004927A patent/UA99308C2/ru unknown
- 2008-09-25 WO PCT/US2008/077669 patent/WO2009042766A1/en active Application Filing
- 2008-09-25 CA CA2700207A patent/CA2700207A1/en not_active Abandoned
- 2008-09-25 RU RU2010116274/04A patent/RU2488591C2/ru not_active IP Right Cessation
- 2008-09-25 US US12/238,054 patent/US8399420B2/en not_active Expired - Fee Related
- 2008-09-25 WO PCT/US2008/077673 patent/WO2009042767A1/en active Application Filing
- 2008-09-25 CN CN2008801085550A patent/CN101877964A/zh active Pending
- 2008-09-25 NZ NZ583923A patent/NZ583923A/en not_active IP Right Cessation
- 2008-09-25 AU AU2008304381A patent/AU2008304381A1/en not_active Abandoned
- 2008-09-25 BR BRPI0817234-0A2A patent/BRPI0817234A2/pt not_active IP Right Cessation
- 2008-09-25 BR BRPI0817269-2A2A patent/BRPI0817269A2/pt not_active IP Right Cessation
- 2008-09-25 AU AU2008304380A patent/AU2008304380A1/en not_active Abandoned
- 2008-09-25 MX MX2010003002A patent/MX2010003002A/es active IP Right Grant
- 2008-09-25 MX MX2010003261A patent/MX2010003261A/es not_active Application Discontinuation
- 2008-09-25 EP EP08834291A patent/EP2197274A4/en not_active Withdrawn
- 2008-09-25 KR KR1020107007252A patent/KR20100072230A/ko not_active Application Discontinuation
- 2008-09-25 CN CN200880108584A patent/CN101815437A/zh active Pending
- 2008-09-25 KR KR1020107008902A patent/KR20100102092A/ko not_active Application Discontinuation
- 2008-09-25 UA UAA201004928A patent/UA99836C2/ru unknown
- 2008-09-25 CA CA2700267A patent/CA2700267A1/en not_active Abandoned
- 2008-09-25 EP EP08832961A patent/EP2205073A4/en not_active Withdrawn
- 2008-09-25 JP JP2010527140A patent/JP2010540556A/ja active Pending
- 2008-09-25 JP JP2010527139A patent/JP2010540555A/ja active Pending
- 2008-09-25 US US12/238,125 patent/US8158605B2/en not_active Expired - Fee Related
-
2010
- 2010-03-08 ZA ZA2010/01660A patent/ZA201001660B/en unknown
- 2010-03-23 IL IL204690A patent/IL204690A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20090209477A1 (en) | 2009-08-20 |
CA2700207A1 (en) | 2009-04-02 |
NZ583923A (en) | 2012-05-25 |
JP2010540556A (ja) | 2010-12-24 |
US20090209482A1 (en) | 2009-08-20 |
EP2205073A4 (en) | 2013-03-06 |
JP2010540555A (ja) | 2010-12-24 |
EP2205073A1 (en) | 2010-07-14 |
ZA201001660B (en) | 2011-05-25 |
CA2700267A1 (en) | 2009-04-02 |
AU2008304381A1 (en) | 2009-04-02 |
KR20100072230A (ko) | 2010-06-30 |
US8399420B2 (en) | 2013-03-19 |
EP2197274A4 (en) | 2013-03-06 |
IL204690A0 (en) | 2010-11-30 |
MX2010003261A (es) | 2010-08-18 |
EP2197274A1 (en) | 2010-06-23 |
WO2009042767A1 (en) | 2009-04-02 |
NZ583824A (en) | 2012-06-29 |
US8158605B2 (en) | 2012-04-17 |
AU2008304380A1 (en) | 2009-04-02 |
CN101877964A (zh) | 2010-11-03 |
RU2010116154A (ru) | 2011-11-10 |
CN101815437A (zh) | 2010-08-25 |
WO2009042766A9 (en) | 2009-05-28 |
WO2009042766A1 (en) | 2009-04-02 |
RU2488591C2 (ru) | 2013-07-27 |
BRPI0817269A2 (pt) | 2014-10-07 |
MX2010003002A (es) | 2010-07-05 |
KR20100102092A (ko) | 2010-09-20 |
UA99308C2 (ru) | 2012-08-10 |
RU2010116274A (ru) | 2011-11-10 |
UA99836C2 (en) | 2012-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0817234A2 (pt) | Análogos de azacitidina e seus usos | |
BRPI0813244A2 (pt) | Compostos e seus usos 708 | |
BRPI0809103A2 (pt) | composições de magnésio e seus usos | |
BRPI0909185A2 (pt) | Derivado de vitamina e e seus usos | |
BRPI0817881A2 (pt) | Compostos orgânicos e seus usos | |
BRPI0910746A2 (pt) | reticuladores e seus usos | |
BRPI0718182A2 (pt) | Oligorribonucleotídeos e seus usos. | |
BRPI0912431A2 (pt) | Combinações de substâncias ativas sinergísticas | |
BR112012000660A2 (pt) | compostos heterociclos e seus usos | |
BRPI0816165A2 (pt) | Dispositivo de citaferese seletiva e seus métodos relacionados | |
BRPI0908853A2 (pt) | composto oligopeptídicos e seus usos | |
BRPI0813647A2 (pt) | Piperazinil oxoalquil tetrahidro-beta-carbolinas e análogos relacionados | |
BRPI0710878A2 (pt) | Compostos orgânicos e seus usos | |
BRPI0812753A2 (pt) | Combinações de substância ativas acaricidas | |
BRPI0818349A2 (pt) | Dispositivo de reconstrução | |
BRPI0814314A2 (pt) | Microbiocidas | |
BRPI0813966A2 (pt) | Usos de mdl-1 | |
BRPI0913640A2 (pt) | substâncias policrômicas e seus usos | |
BRPI0906498A2 (pt) | Anticorpo ron e seus usos | |
BRPI0921862A2 (pt) | inibidores de raf e seus usos | |
BRPI0814188A2 (pt) | Formulações | |
BRPI0814876A2 (pt) | Análogos de pirona fosforilados e métodos | |
BRPI0812916A2 (pt) | Chupeta | |
DE502008001632D1 (de) | Karosserieaufbau | |
EP2178482A4 (en) | VACCINATORY STRUCTURE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |